文献
J-GLOBAL ID:201902257131956746
整理番号:19A0857010
癌におけるインドールアミン-2,3-ジオキシゲナーゼの標的化:科学的根拠と臨床的証拠【JST・京大機械翻訳】
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
著者 (11件):
Ricciuti Biagio
(Department of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy)
,
Leonardi Giulia Costanza
(Department of Pathology, Children’s Hospital, Boston, MA, United States)
,
Leonardi Giulia Costanza
(Department of Biomedical and Biotechnological Sciences, Pathology and Oncology Section, University of Catania, Catania, Italy.)
,
Puccetti Paolo
(Department of Experimental Medicine, University of Perugia, Perugia, Italy.)
,
Fallarino Francesca
(Department of Experimental Medicine, University of Perugia, Perugia, Italy.)
,
Bianconi Vanessa
(Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy)
,
Sahebkar Amirhossein
(Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran)
,
Sahebkar Amirhossein
(Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran)
,
Baglivo Sara
(Department of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy)
,
Chiari Rita
(Department of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy)
,
Pirro Matteo
(Unit of Internal Medicine, Department of Medicine, University of Perugia, Perugia, Italy)
資料名:
Pharmacology & Therapeutics
(Pharmacology & Therapeutics)
巻:
196
ページ:
105-116
発行年:
2019年
JST資料番号:
C0031D
ISSN:
0163-7258
CODEN:
PHTHDT
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)